In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes

Nature Genetics

Volumn 38, Issue 4, 2006, Pages 479-483

  Kissler, Stephan ^a   Stern, Patrick ^a   Takahashi, Kazue ^b   Hunter, Kara ^c   Peterson, Laurence B ^d   Wicker, Linda S ^c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA MODIFICATION; GENE LOCUS; GENE MUTATION; GENE SILENCING; HAPLOTYPE; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; ION TRANSPORT; LENTIVIRINAE; MALE; MORBIDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RNA INTERFERENCE; TRANSGENE;

ANIMALS; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; MALE; MICE; MICE, INBRED NOD; RNA INTERFERENCE;

ANIMALIA; LENTIVIRUS; MAMMALIA;

EID: 33645395980     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1766     Document Type: Article

References (29)

1. Makino, S. et al. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29, 1-13 (1980).
2. Todd, J.A. & Wicker, L.S. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 15, 387-395 (2001).
3. Ueda, H. et al. Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature 423, 506-511 (2003).
4. Vijayakrishnan, L. et al. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity 20, 563-575 (2004).
5. Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811 (1998).
6. Elbashir, S.M. et al. Duplexes of 21-nucleotides RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001).
7. Vidal, S.M., Malo, D., Vogan, K., Skamene, E. & Gros, P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73, 469-485 (1993).
8. Vidal, S. et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular pathogens is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182, 655-666 (1995).
9. Wojciechowski, W., DeSanctis, J., Skamene, E. & Radzioch, D. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guerin involves class II transactivator and depends on the Nramp1 gene. J. Immunol. 163, 2688-2696 (1999).
10. Wicker, L.S. et al. Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla-4 and Nramp-1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. J. Immunol. 173, 164-173 (2004).
11. Lois, C., Hong, E.J., Pease, S., Brown, E.J. & Baltimore, D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295, 868-872 (2002).
12. Kanagawa, O., Xu, G., Tevaarwerk, A. & Vaupel, B.A. Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-γ receptor loci. J. Immunol. 164, 3919-3923 (2000).
13. Rubinson, D.A. et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33, 401-406 (2003).
14. Tiscornia, G., Singer, O., Ikawa, M. & Verma, I.M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. USA 100, 1844-1848 (2003).
15. Lu, W., Yamamoto, V., Ortega, B. & Baltimore, D. Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell 119, 97-108 (2004).
16. Kwaks, T.H. et al. Identification of anti-repressor elements that confer high and stable protein production in mammalian cells. Nat. Biotechnol. 21, 553-558 (2003).
17. Klehr, D., Maass, K. & Bode, J. Scaffold-attached regions from the human interferon beta domain can be used to enhance the stable expression of genes under the control of various promoters. Biochemistry 30, 1264-1270 (1991).
18. Schwarz, D.S. et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199-208 (2003).
19. Khvorova, A., Reynolds, A. & Jayasena, S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 115, 209-216 (2003).
20. Reynolds, A. et al. Rational siRNA design for RNA interference. Nat. Biotechnol. 22, 326-330 (2004).
21. Nishino, M. et al. Functional polymorphism in Z-DNA-forming motif of promoter of SLC11A1 gene and type 1 diabetes in Japanese subjects: Association study and meta-analysis. Metabolism 54, 628-633 (2005).
22. Takahashi, K. et al. Promoter polymorphism of SLC11A1 (formerly NRAMP1) confers susceptibility to autoimmune type 1 diabetes mellitus in Japanese. Tissue Antigens 63, 231-236 (2004).
23. Sanjeevi, C.B. et al. Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis. Arthritis Rheum. 43, 1397-1404 (2000).
24. Shaw, M.A. et al. Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35. J. Med. Genet. 33, 672-677 (1996).
25. Steinman, L. & Zamvil, S.S. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 26, 565-571 (2005).
26. Qiu, S., Adema, C.M. & Lane, T. A computational study of off-target effects of RNA interference. Nucleic Acids Res. 33, 1834-1847 (2005).
27. Jackson, A.L. & Linsley, P.S. Noise amidst the silence: off-target effects of siRNAs? Trends Genet 20, 521-524 (2004).
28. Searle, S. & Blackwell, J.M. Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J. Med. Genet. 36, 295-299 (1999).
29. Hill, N.J. et al. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA-4/IDDM12 and NRAMP1 loci in humans. Diabetes 49, 1744-1747 (2000).